LINC01123 and neoplasm: LINC01123 is upregulated in a wide array of human tumors, and elevated expression levels of LINC01123 in cancerous samples correlate with adverse clinicopathological features and poor prognosis, including lymph node metastasis, tumor size, clinical stage, overall survival (OS), disease-free survival (DFS), and biochemical recurrence (BCR)-free survival.